Boehringer Japan Unit Plans 15 New Drugs Over Next Five Years
This article was originally published in PharmAsia News
Executive Summary
Boehringer Ingelheim Japan said it has plans to bring 15 innovative drugs to the local market over the next five years, beginning with cancer and hepatitis C treatments.